🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationCompounded vs brand name and honestly I cannot tell the difference — what worked for you? Page 2

Compounded vs brand name and honestly I cannot tell the difference — what worked for you?

PharmD_Rodriguez Wed, Jan 24, 2024 at 12:54 AM 12 replies 2,242 viewsPage 2 of 3
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Jan 24, 2024 at 3:44 AM#6

Quin makes valid points but "guaranteed potency and purity" applies to compounded products from good pharmacies too. I've tested vials from three different 503B facilities and all came back between 97-103% potency via Janoshik. That's within the same USP specifications as branded products.

The real value proposition of brand is the delivery device (prefilled pen is undeniably more convenient) and the clinical trial data backing specific dose titration schedules.

41 14robert_kc, dan_philly, MeganSA_TX and 38 others
Reply Quote Save Share Report
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
Jan 24, 2024 at 4:01 AM#7

Bottom line for anyone reading: if your insurance covers brand and you can get it for $25/month, do that. If you're paying out of pocket and looking at $1,200+/month vs $130-200/month, compounded from a reputable 503B facility is a legitimate option that millions of people are using safely.

The "right" choice depends entirely on your financial situation and risk tolerance. 💰

Last edited: Jan 24, 2024 at 7:01 AM
43 17tane_welly, Dr.PathRoch, mona_PHX and 40 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Jan 24, 2024 at 4:18 AM#8

Has anyone looked into the Novo Nordisk patient assistance programs? I applied for one but got denied because my income was "too high" at $55k/year. Apparently their threshold is pretty low. Feels like another dead end.

Last edited: Jan 24, 2024 at 8:18 AM
22 14denise_HTX, raj_cambridge, ingrid_STO and 19 others
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Jan 24, 2024 at 4:35 AM#9

Yeah, the PAP income thresholds are frustratingly low — typically 400% of federal poverty level or below. For a single person that's about $60,840 in 2026. If you're even slightly above that, you're out of luck. The cost savings cards are better but only work with commercial insurance, not Medicare/Medicaid.

The system is broken. That's why compounding exists. 🤷‍♀️

13 23Dr.LeslieOBGYN, MikeNYC_runner and 10 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register